Effects of Digital Pelvic Floor Muscle Training in Patients With Multiple Sclerosis Having Lower Urinary Tract Symptoms

NCT ID: NCT04759391

Last Updated: 2021-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-28

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to investigate the effects of digital pelvic floor muscle training and lifestyle recommendations in patients with Multiple Sclerosis having lower urinary tract symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system. Lower urinary tract symptoms (LUTS) are very common in MS. Pelvic floor muscle training (PFMT) is one of the first-line choices for the conservative treatment of LUTS.

According to our knowledge, no study has investigated the effects of digital pelvic floor muscle training and lifestyle recommendations in MS having LUTS, yet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Urinary Tract Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly divided into two groups (control and exercise) for treatment.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise group

Lifestyle recommendations as well as digital pelvic floor muscle training to the exercise group

Group Type EXPERIMENTAL

Exercise

Intervention Type OTHER

Pelvic floor muscle training program planned under the supervision of a physiotherapist was applied and followed to the exercise group, using the digital application.

Lifestyle recommendations

Intervention Type OTHER

Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms

Control group

Lifestyle recommendations will be given to the control group

Group Type ACTIVE_COMPARATOR

Lifestyle recommendations

Intervention Type OTHER

Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Pelvic floor muscle training program planned under the supervision of a physiotherapist was applied and followed to the exercise group, using the digital application.

Intervention Type OTHER

Lifestyle recommendations

Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a diagnosis of MS and having at least two of the lower urinary symptoms
* Not having an attack in the last 1 month,
* No change in medical treatment in the last 3 months
* "Expanded disability status scale-EDSS" score is less than 6.5
* Not having any cognitive problems that would hinder cooperation and understanding
* Those who use digital devices such as computers, laptops, smartphones and tablets
* Volunteering to participate in the study

Exclusion Criteria

* Pregnancy status
* Active urinary tract infection
* Another neurological disease that can cause incontinence
* A history of malignancy
* Prostate surgery
* Those with missing evaluation parameters
* Those who do not regularly participate in treatment programs
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ataturk Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seyda TOPRAK CELENAY

associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Seyda Toprak Celenay

Role: PRINCIPAL_INVESTIGATOR

Ankara Yildirim Beyazıt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara Yildirim Beyazit University

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Seyda Toprak Celenay

Role: CONTACT

+90312 906 1000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Seyda Toprak Celenay

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/02/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.